Curtis BM, Scharnowske S, Watson AJ (September 1992). Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc. Natl. Acad. Sci. U.S.A.89 (17): 8356–60. PMID1518869. PMC49917. DOI: 10.1073/pnas.89.17.8356.
Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984). The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature312 (5996): 763–7. PMID6096719. DOI: 10.1038/312763a0.
Thomas G (October 2002). Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nature Reviews. Molecular Cell Biology3 (10): 753–66. PMID12360192. PMC1964754. DOI: 10.1038/nrm934.
Hallenberger S, Bosch V, Angliker H, Shaw E, Klenk HD, Garten W (November 1992). Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature360 (6402): 358–61. PMID1360148. DOI: 10.1038/360358a0.
Zhu P, Winkler H, Chertova E, Taylor KA, Roux KH (November 2008). Cryoelectron tomography of HIV-1 envelope spikes: further evidence for tripod-like legs. PLOS Pathog.4 (11): e1000203. PMID19008954. PMC2577619. DOI: 10.1371/journal.ppat.1000203.
Wyatt R, Kwong PD, Desjardins E, Sweet RW, Robinson J, Hendrickson WA, Sodroski JG (1998). The antigenic structure of the HIV gp120 envelope glycoprotein. Nature393 (6686): 705–711. PMID9641684. DOI: 10.1038/31514.
Novitsky V, Lagakos S, Herzig M, Bonney C, Kebaabetswe L, Rossenkhan R, Nkwe D, Margolin L, Musonda R, Moyo S, Woldegabriel E, van Widenfelt E, Makhema J, Essex M (January 2009). Evolution of proviral gp120 over the first year of HIV-1 subtype C infection. Virology383 (1): 47–59. PMID18973914. PMC2642736. DOI: 10.1016/j.virol.2008.09.017.
Wood N, Bhattacharya T, Keele BF, Giorgi E, Liu M, Gaschen B, Daniels M, Ferrari G, Haynes BF, McMichael A, Shaw GM, Hahn BH, Korber B, Seoighe C (May 2009). HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLOS Pathog.5 (5): e1000414. PMID19424423. PMC2671846. DOI: 10.1371/journal.ppat.1000414.
Liu Y, Curlin ME, Diem K, Zhao H, Ghosh AK, Zhu H, Woodward AS, Maenza J, Stevens CE, Stekler J, Collier AC, Genowati I, Deng WZioni R, Corey L, Zhu T, Mullins JI (May 2008). Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses. Virology374 (2): 229–33. PMID18314154. PMC2441482. DOI: 10.1016/j.virol.2008.01.029.
Frost SD, Wrin T, Smith DM, Kosakovsky Pond SL, Liu Y, Paxinos E, Chappey C, Galovich J, Beauchaine J, Petropoulos CJ, Little SJ, Richman DD (December 2005). Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. U.S.A.102 (51): 18514–9. PMID16339909. PMC1310509. DOI: 10.1073/pnas.0504658102.
Barbas CF, Björling E, Chiodi F, Dunlop N, Cababa D, Jones TM, Zebedee SL, Persson MA, Nara PL, Norrby E (October 1992). Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. U.S.A.89 (19): 9339–43. PMID1384050. PMC50122. DOI: 10.1073/pnas.89.19.9339.
Ashish, null, Solanki, Ashish K., Boone, Christopher D., Krueger, Joanna K. (1 januari 2010). Global structure of HIV-1 neutralizing antibody IgG1 b12 is asymmetric. Biochemical and Biophysical Research Communications391 (1): 947–951. ISSN: 1090-2104. PMID19995532. DOI: 10.1016/j.bbrc.2009.11.170.
Solanki, Ashish K., Rathore, Yogendra S., Badmalia, Maulik D., Dhoke, Reema R., Nath, Samir K. (12 december 2014). Global Shape and Ligand Binding Efficiency of the HIV-1-neutralizing Antibodies Differ from Those of Antibodies That Cannot Neutralize HIV-1. The Journal of Biological Chemistry289 (50): 34780–34800. ISSN: 0021-9258. PMID25331945. PMC4263879. DOI: 10.1074/jbc.M114.563486.
Chien, Peter C., Cohen, Sandra, Kleeberger, Cynthia, Giorgi, Janis, Phair, John (15 juli 2002). High levels of antibodies to the CD4 binding domain of human immunodeficiency virus type 1 glycoprotein 120 are associated with faster disease progression. The Journal of Infectious Diseases186 (2): 205–213. ISSN: 0022-1899. PMID12134256. DOI: 10.1086/341297.
Bachis A, Avdoshina V, Zecca L, Parsadanian M, Mocchetti I (2012). Human Immunodeficiency Virus Type 1 Alters Brain-Derived Neurotrophic Factor Processing in Neurons. The Journal of Neuroscience32 (28): 9477–9484. PMID22787033. PMC3408006. DOI: 10.1523/JNEUROSCI.0865-12.2012.
Thomas S, Mayer L, Sperber K (2009). Mitochondria influence Fas expression in gp120-induced apoptosis of neuronal cells. Int. J. Neurosci.119 (2): 157–65. PMID19125371. DOI: 10.1080/00207450802335537.
Price TO, Ercal N, Nakaoke R, Banks WA (May 2005). HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res.1045 (1–2): 57–63. PMID15910762. DOI: 10.1016/j.brainres.2005.03.031.
Yang B, Akhter S, Chaudhuri A, Kanmogne GD (March 2009). HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood–brain barrier: modulatory effects of STAT1 signaling. Microvasc. Res.77 (2): 212–9. PMID19103208. PMC3715090. DOI: 10.1016/j.mvr.2008.11.003.
nih.gov
ncbi.nlm.nih.gov
Curtis BM, Scharnowske S, Watson AJ (September 1992). Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc. Natl. Acad. Sci. U.S.A.89 (17): 8356–60. PMID1518869. PMC49917. DOI: 10.1073/pnas.89.17.8356.
Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA (1984). The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature312 (5996): 763–7. PMID6096719. DOI: 10.1038/312763a0.
Thomas G (October 2002). Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nature Reviews. Molecular Cell Biology3 (10): 753–66. PMID12360192. PMC1964754. DOI: 10.1038/nrm934.
Hallenberger S, Bosch V, Angliker H, Shaw E, Klenk HD, Garten W (November 1992). Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature360 (6402): 358–61. PMID1360148. DOI: 10.1038/360358a0.
Zhu P, Winkler H, Chertova E, Taylor KA, Roux KH (November 2008). Cryoelectron tomography of HIV-1 envelope spikes: further evidence for tripod-like legs. PLOS Pathog.4 (11): e1000203. PMID19008954. PMC2577619. DOI: 10.1371/journal.ppat.1000203.
Wyatt R, Kwong PD, Desjardins E, Sweet RW, Robinson J, Hendrickson WA, Sodroski JG (1998). The antigenic structure of the HIV gp120 envelope glycoprotein. Nature393 (6686): 705–711. PMID9641684. DOI: 10.1038/31514.
Novitsky V, Lagakos S, Herzig M, Bonney C, Kebaabetswe L, Rossenkhan R, Nkwe D, Margolin L, Musonda R, Moyo S, Woldegabriel E, van Widenfelt E, Makhema J, Essex M (January 2009). Evolution of proviral gp120 over the first year of HIV-1 subtype C infection. Virology383 (1): 47–59. PMID18973914. PMC2642736. DOI: 10.1016/j.virol.2008.09.017.
Wood N, Bhattacharya T, Keele BF, Giorgi E, Liu M, Gaschen B, Daniels M, Ferrari G, Haynes BF, McMichael A, Shaw GM, Hahn BH, Korber B, Seoighe C (May 2009). HIV evolution in early infection: selection pressures, patterns of insertion and deletion, and the impact of APOBEC. PLOS Pathog.5 (5): e1000414. PMID19424423. PMC2671846. DOI: 10.1371/journal.ppat.1000414.
Liu Y, Curlin ME, Diem K, Zhao H, Ghosh AK, Zhu H, Woodward AS, Maenza J, Stevens CE, Stekler J, Collier AC, Genowati I, Deng WZioni R, Corey L, Zhu T, Mullins JI (May 2008). Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses. Virology374 (2): 229–33. PMID18314154. PMC2441482. DOI: 10.1016/j.virol.2008.01.029.
Frost SD, Wrin T, Smith DM, Kosakovsky Pond SL, Liu Y, Paxinos E, Chappey C, Galovich J, Beauchaine J, Petropoulos CJ, Little SJ, Richman DD (December 2005). Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. U.S.A.102 (51): 18514–9. PMID16339909. PMC1310509. DOI: 10.1073/pnas.0504658102.
Barbas CF, Björling E, Chiodi F, Dunlop N, Cababa D, Jones TM, Zebedee SL, Persson MA, Nara PL, Norrby E (October 1992). Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc. Natl. Acad. Sci. U.S.A.89 (19): 9339–43. PMID1384050. PMC50122. DOI: 10.1073/pnas.89.19.9339.
Ashish, null, Solanki, Ashish K., Boone, Christopher D., Krueger, Joanna K. (1 januari 2010). Global structure of HIV-1 neutralizing antibody IgG1 b12 is asymmetric. Biochemical and Biophysical Research Communications391 (1): 947–951. ISSN: 1090-2104. PMID19995532. DOI: 10.1016/j.bbrc.2009.11.170.
Solanki, Ashish K., Rathore, Yogendra S., Badmalia, Maulik D., Dhoke, Reema R., Nath, Samir K. (12 december 2014). Global Shape and Ligand Binding Efficiency of the HIV-1-neutralizing Antibodies Differ from Those of Antibodies That Cannot Neutralize HIV-1. The Journal of Biological Chemistry289 (50): 34780–34800. ISSN: 0021-9258. PMID25331945. PMC4263879. DOI: 10.1074/jbc.M114.563486.
Chien, Peter C., Cohen, Sandra, Kleeberger, Cynthia, Giorgi, Janis, Phair, John (15 juli 2002). High levels of antibodies to the CD4 binding domain of human immunodeficiency virus type 1 glycoprotein 120 are associated with faster disease progression. The Journal of Infectious Diseases186 (2): 205–213. ISSN: 0022-1899. PMID12134256. DOI: 10.1086/341297.
Bachis A, Avdoshina V, Zecca L, Parsadanian M, Mocchetti I (2012). Human Immunodeficiency Virus Type 1 Alters Brain-Derived Neurotrophic Factor Processing in Neurons. The Journal of Neuroscience32 (28): 9477–9484. PMID22787033. PMC3408006. DOI: 10.1523/JNEUROSCI.0865-12.2012.
Thomas S, Mayer L, Sperber K (2009). Mitochondria influence Fas expression in gp120-induced apoptosis of neuronal cells. Int. J. Neurosci.119 (2): 157–65. PMID19125371. DOI: 10.1080/00207450802335537.
Price TO, Ercal N, Nakaoke R, Banks WA (May 2005). HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells. Brain Res.1045 (1–2): 57–63. PMID15910762. DOI: 10.1016/j.brainres.2005.03.031.
Yang B, Akhter S, Chaudhuri A, Kanmogne GD (March 2009). HIV-1 gp120 induces cytokine expression, leukocyte adhesion, and transmigration across the blood–brain barrier: modulatory effects of STAT1 signaling. Microvasc. Res.77 (2): 212–9. PMID19103208. PMC3715090. DOI: 10.1016/j.mvr.2008.11.003.
Ashish, null, Solanki, Ashish K., Boone, Christopher D., Krueger, Joanna K. (1 januari 2010). Global structure of HIV-1 neutralizing antibody IgG1 b12 is asymmetric. Biochemical and Biophysical Research Communications391 (1): 947–951. ISSN: 1090-2104. PMID19995532. DOI: 10.1016/j.bbrc.2009.11.170.
Solanki, Ashish K., Rathore, Yogendra S., Badmalia, Maulik D., Dhoke, Reema R., Nath, Samir K. (12 december 2014). Global Shape and Ligand Binding Efficiency of the HIV-1-neutralizing Antibodies Differ from Those of Antibodies That Cannot Neutralize HIV-1. The Journal of Biological Chemistry289 (50): 34780–34800. ISSN: 0021-9258. PMID25331945. PMC4263879. DOI: 10.1074/jbc.M114.563486.
Chien, Peter C., Cohen, Sandra, Kleeberger, Cynthia, Giorgi, Janis, Phair, John (15 juli 2002). High levels of antibodies to the CD4 binding domain of human immunodeficiency virus type 1 glycoprotein 120 are associated with faster disease progression. The Journal of Infectious Diseases186 (2): 205–213. ISSN: 0022-1899. PMID12134256. DOI: 10.1086/341297.
